Ads
related to: prostate+cancer%2C+cell- Clinical Study Info
Learn About Clinical Study Results
For a Prostate Cancer Treatment
- Patient Support Program
Support to Help Your Patients
Get Started and Stay on Track
- Coverage for Rx Treatment
Learn About Coverage
In Your Area.
- Formulary Lookup Tool
View our Formulary Lookup
For a Prostate Cancer Treatment
- Important Safety Info
View Safety Information
Prostate Cancer Treatment Pills
- Sign Up For Updates
Prostate Cancer Treatment Options
Get Information & Updates
- Clinical Study Info
Search results
Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting
WRBL Columbus· 6 days agoSAN DIEGO, May 9, 2024 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based ...
Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung...
Nature· 2 days agoLung adenocarcinoma (LUAD) is one of the most prevalent types of cancer. Ubiquitination is crucial in modulating cell proliferation and aerobic glycolysis ...
Rome Health wound care raises awareness, provides hope for radiation injuries
Rome Sentinel· 2 days agoCancer recovery rates are increasing, thanks to early detection and advancements in treatments. Of...
AI advancements make the leap into 3D pathology possible
Medical Xpress· 7 days agoIn a new study, researchers from Mass General Brigham and their collaborators present Tripath: new, deep learning models that can use 3D pathology datasets to make clinical outcome predictions ...
Natesto: Side effects and what to do about them
Medical News Today· 2 days agoNatesto (testosterone) is a brand-name nasal spray that’s prescribed to treat low testosterone in certain adults. As with other drugs, Natesto can cause...
Wedbush Boosts Janux Therapeutics (NASDAQ:JANX) Price Target to $74.00
ETF DAILY NEWS· 5 days agoJanux Therapeutics (NASDAQ:JANX – Free Report) had its target price increased by Wedbush from $53.00 to $74.00 in a research note published on Wednesday morning, Marketbeat reports. The brokerage ...
Caris Life Sciences to Showcase Extensive Research Highlighting the Clinical Value of Comprehensive...
FOX 5 San Diego· 2 days agoCaris Life Sciences® (Caris), the leading next-generation AI TechBio company and precision medicine pioneer, today announced that the company and collaborators from the biopharma industry and ...
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting
WPRI Providence· 3 days agoThe volume of data being presented by Astellas reinforces its commitment to changing the course of cancer treatment through targeted therapies for hard-to-treat cancers ...
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim...
Morningstar· 7 days agoPresentation of interim TAMARACK Phase 2 study data: updated safety and preliminary efficacy of vobra duo in mCRPC patientsConference call scheduled for today at 4:30 p.m. ET ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ
Mission Possible: Researching nanobubbles to better fight cancer
WKYC Cleveland· 4 days agoCase Western Reserve University has over a decade of research into an innovative way to detect and...